ACCELERATING THE FUTURE OF
PATHOGEN DISCOVERY

One conversational interface replaces your entire bioinformatics stack. Classify, assemble, dock, mutate, score — in plain English.

Therapeutic Discovery
Precision Diagnostics
Vaccine Innovation
1.8M+
Reads Classified
96.4%
Accuracy
6
Integrated Engines
< 15 min
Avg Classification

Nine engines. One conversation.

From raw sequencing data to engineered proteins — every step controlled through natural language.

UploadClassifyDetectExtractAssemblePhylogenyDockMutateScoreCA+H
Step 01 / 09

Upload

Ingest raw FASTQ sequencing data from any sequencer or cloud storage provider.

Platform Features

Built for real science.

Every tool a bioinformatician needs, powered by AI and accessible through conversation.

‹›
app.convergentah.com/evolve
Evolve
Jobs (8)Workflows (2)
AllRunningCompletedFailedDockingMutationModeling
HBB-Hemoglobin Docking
+ Protein Docking
Completed
dockinghemoglobinCompleted in 93m 30s
Spike-ACE2 Structure Prediction
+ AI Structure Prediction
Running
modelingcovidboltz
Spike RBD Mutations
+ Mutation Generation
Completed
mutationspikerbdCompleted in 2m 22s
Top Docking Complexes Interaction
+ Interaction Scoring
Completed
interactionprodigyCompleted in 5m 15s
Combined Scoring
+ Score Aggregation
Completed
scoringCompleted in 1m 12s
Why Convergent A+H

Your Complete Workflow. Unified.

Convergent A+H unifies your entire bioinformatics stack into one conversational interface — so your team can focus on discovery, not infrastructure.

Partner With Us
01

No command line.

Every tool runs through a natural language interface. No scripting, no configuration files, no terminal.

02

No scripting.

Complex multi-step pipelines assembled automatically from your plain-English description of the goal.

03

No degree required.

Kraken2, MEGAHIT, metaSPAdes, LightDock, Boltz — all accessible to any researcher, any background.

Market Sectors

Built for your science.

10x faster protein design cycles

The operating system for computational protein engineering.

  • Design, dock, mutate, and score proteins conversationally
  • Boltz AI structure prediction + LightDock molecular docking
  • Automated mutation libraries with binding affinity scoring
Our Team

The people behind Convergent A+H.

Scientists, engineers, and builders working to make bioinformatics accessible to everyone.

Leadership
Rick Vierling, PhD
Rick Vierling, PhD
CEO
Ned Saleh, PhD
Ned Saleh, PhD
Research & Product Advisor
Tony Rock
Tony Rock
Advisor, GTM & Value Creation
Heath McBurnett
Heath McBurnett
CTO
Indy Beck
Indy Beck
Chief AI Architect
John Faith
John Faith
SVP Engineering
Blake Ashby
Blake Ashby
Advisor, Administration & GRC
Advisors & Board
Dan Hardy, PhD
Dan Hardy, PhD
Research & Product Advisor
Robert Bradley, PhD
Robert Bradley, PhD
Research Advisor
Jim Mueller
Jim Mueller
Board, Advisor

Our Technology

Proprietary Platform

Next-Generation miRNA Biomarker Platform

Convergent Animal + Human Health's proprietary miRNA biomarker technology represents a fundamental advance in pathogen surveillance. By identifying micro-RNA signatures unique to specific pathogens and disease states, our platform achieves detection sensitivity far exceeding conventional diagnostic approaches.

The platform's AI-driven bioinformatics layer continuously maps cross-species biological pathways, creating a living intelligence network that identifies emergent pandemic threats in animal populations before zoonotic transmission to humans occurs.

Platform Specifications
Platform TypeNext-Generation miRNA Biomarker Detection
MethodologyAI-Powered Bioinformatics Analysis
Surveillance ScopeLivestock, Wildlife & Zoonotic Pathogens
Detection PhasePre-transmission, Early Biological Stage
Data IntegrationCross-species Molecular Pathway Mapping
ApplicationTherapeutic, Diagnostic & Vaccine Pipelines

Partner With Convah

We are actively seeking research collaborators, institutional partners, and strategic investors aligned with the One Health mission.

One Health Mission

We bridge the gap between animal pathogen surveillance and human therapeutic development — identifying pandemic threats before they cross species boundaries.

10B+
Reads Processed
99.2%
Accuracy Rate
3×
Faster Discovery
We Work With
Research Institutions & Universities
Government & NGO Program Officers
Biotech & Pharmaceutical Companies
Venture & Strategic Investors
Public Health Agencies

Partnership Inquiry

All inquiries reviewed by our scientific leadership

All inquiries are reviewed by our scientific leadership within 1–2 business days.